Fact CheckerSign in

NCT03865355Completed

Blood and Cerebrospinal Fluid Metabolomic Profile in Glioma Patients

Unique Blood and CSF Metabolic Profile Association With Gliomas in Adults

Source: ClinicalTrials.gov · Last updated 14 Nov 2024

Brief summary (registry, in English)

This is an exploratory, non-interventional and translational clinical study. The aim of this study is to analyze blood and cerebrospinal fluid metabolomic profile in glioma patients.

Status (registry)
Completed
Study type
Observational
Enrollment
50 (actual)
First submitted
26 Feb 2019
Start date
13 Mar 2019
Primary completion date
11 Apr 2024
Lead sponsor
Novosibirsk State University
Diseases
Glioblastoma
NCT number
NCT03865355

What you commit to

  • Study type: Observational
  • Participants enrolled: 50
  • From 13 Mar 2019 to the primary completion date, 11 Apr 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Prior Radiotherapy to the central nervous system
  • Prior Chemotherapy within the last 5 years
  • Any prior central nervous system malignancy
  • Any surgery during last 6 month

Who the study is looking for

  • All patients with suspected newly diagnosed glioma (grade I, II, III or glioblastoma) with planned surgical intervention (resection or biopsy).
  • Patient aged 18 years or older
  • Patients have to be able to give informed consent

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Novosibirsk State University
Coordinator of this site? Confirm its status		NovosibirskRussiaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.